US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Charlton Aria Acquisition Corporation (CHARU) 銘柄情報

Charlton Aria Acquisition Corporation (CHARU)

10.80

0.00

(0.00%)

終了 7月11日 5:00AM

0.00

0.00

(0.00%)

取引時間後: 6:39AM

Charlton Aria Acquisition Corporation (CHARU) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

10.80

( - )

買値

0.0005

売値

66,232.00

出来高

-

0.00 日の範囲 0.00

10.25 52 週間の範囲 12.50

前日終値

10.80

始値

-

時刻

最終取引時間

平均取引量 (3 か月)

66

財務取引量

-

VWAP

-

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Charlton Aria Acquisition Corporation Announces Receipt of Nasdaq Notice Regarding Delinquent Filing of Quarterly Report on Form 10-Q

Wilmington, DE, May 27, 2026 (GLOBE NEWSWIRE) -- Charlton Aria Acquisition Corporation (Nasdaq: CHARU), a Cayman Islands exempted company (the...

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Wilmington, DE, April 27, 2026 (GLOBE NEWSWIRE) -- Charlton Aria Acquisition Corporation (Nasdaq: CHARU), a Cayman Islands exempted company...

Form 8-K - Current report

Charlton Aria Acquisition Corporation Announces Receipt of Nasdaq Notice Regarding Delinquent Filing of Annual Report on Form 10-K

Wilmington, DE, April 21, 2026 (GLOBE NEWSWIRE) -- Charlton Aria Acquisition Corporation (Nasdaq: CHARU), a Cayman Islands exempted company...

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	10.8	10.8	10.8	0	0	CS
4	0	0	10.8	10.8	10.8	0	0	CS
12	0.11	1.02899906455	10.69	12.05	10.66	66	11.06971344	CS
26	0.3	2.85714285714	10.5	12.05	10.5	69	10.84610246	CS
52	0.39	3.74639769452	10.41	12.5	10.25	159	10.59983889	CS
156	0.85	8.54271356784	9.95	12.5	9.95	7583	9.99083633	CS
260	0.85	8.54271356784	9.95	12.5	9.95	7583	9.99083633	CS

CHARU - Frequently Asked Questions (FAQ)

What is the current Charlton Aria Acquisition Corporation share price?

The current share price of Charlton Aria Acquisition Corporation is US$ 10.80

What is the 1 year trading range for Charlton Aria Acquisition Corporation share price?

Charlton Aria Acquisition Corporation has traded in the range of US$ 10.25 to US$ 12.50 during the past year

shajandr

shajandr 10分前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 20分前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Kool Aid Man

Kool Aid Man 23分前

Q:--"Why would a Royal Qatari Sheikh worth multi-millions need an infamous, maxed out, toxic ticker littered with legal landmines in order to 'self fund' mining and drilling on at least 3 continents then split his profits with decades of old HIRU bag holders???"

A: He doesn't

shajandr

shajandr 26分前

Roofie the prison janitor.

jjjjjjjj

jjjjjjjj 34分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN!
Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. DAMNED IF IT GOES DOWN! Is today Mond

Kool Aid Man

Kool Aid Man 34分前

Has the bank said "no money was lost"? Then why are they suing?

rosemountbomber

rosemountbomber 55分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 57分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 1時間前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 1時間前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 1時間前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 1時間前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 1時間前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 1時間前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Genz2 2時間前

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 2時間前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 2時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Charlton Aria Acquisition

Grupo Carso Sa de CV (PK)

4.701% 31/05/33 4.701% 3...

0.8% due 23mar2046 0.8% ...

Shelton Equity Premium I...

Blonder Tongue Laborator...

Franklin MSCI Emerging M...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。